about
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. ...
Read More
7.88
-0.15
(-1.87%)
1.1M
XNAS Volume
XNAS 21 Sep, 2026 5:30 PM (EDT)
Low Financial Strength
Expensive Valuation
Technically Bearish
Weak Stock
These stocks have poor scores across the board. Investors should be very cautious with these stocks
View Similar
Embed DVM
Regenxbio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..